新生儿治疗性低温期间的药理动力学:从病理生理学到转化知识和生理基础药理动力学 (PBPK) 建模
Karen Leys1, Marina-Stefania Stroe2, Pieter Annaert1,3
1Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences KU Leuven, Leuven, Belgium.
Expert opinion on drug metabolism & toxicology
|July 20, 2023
概括
周产期窒息 (PA) 和治疗性低温 (TH) 影响新生儿药物药理动力学. 本综述综合了知识,以改善药物开发和神经发育结果的新生儿与PA.
科学领域:
- 新生儿生理学和药理学
- 治疗性低温症的研究.
- 为新生儿开发药物的开发.
背景情况:
- 围产阶段窒息 (PA) 导致新生儿显著的发病率和死亡率.
- 治疗性低温 (TH) 是唯一有效的治疗缺氧缺血性脑病变后的PA.
- PA和TH复杂的新生儿药理动力学 (PK) 和药理动力学 (PD),需要谨慎的药物管理.
研究的目的:
- 审查有关新生儿PA/TH病理生理学的现有知识.
- 总结人类新生儿PK的支持性药物疗法.
- 探索整合临床前和临床数据用于预测性PK模型.
主要方法:
- 在PubMed的文献综述 (直到2022年11月).
- 对体内猪模型的分析,以区分PA和TH对PK的影响.
- 人类新生儿PK数据对支持性治疗的总结.
主要成果:
- 在体内猪模型有助于区分PA和TH对PK的影响.
- 总结了关键辅助药物的人类新生儿PK数据.
- 基于生理学的PK (PBPK) 框架可以整合各种数据进行预测.
结论:
- 了解PA/TH对PK的影响对于优化新生儿护理至关重要.
- 整合临床,临床前和分子数据支持预测PBPK建模.
- 需要进一步的研究和专家合作,以推进新生儿PA/TH的药物开发.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
109
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
Pharmacokinetic Models: Overview
794
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
794
Model Approaches for Pharmacokinetic Data: Physiological Models
78
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
78
Physiological Pharmacokinetic Models: Assumption with Protein Binding
75
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
75
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Nonlinear Pharmacokinetics: Overview
445
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
445


